Title: Protocol%20for%20Thesis%20Faculty%20of%20Medical%20Sciences%20University%20of%20Delhi
1Protocol for Thesis Faculty of Medical
SciencesUniversity of Delhi
- Dr XYZ
- Postgraduate student
- Department of ABCD
- University College of Medical Sciences GTB
Hospital
2Supervisor Dr. A Professor Dept. of
ABCD UCMS GTB Hospital Delhi Co-Supervisor
s Dr. B Professor Dept. of EFGH UCMS
GTB Hospital Delhi Dr. C Professor
Head Dept. of IJKL UCMS GTB
Hospital Delhi
3Title
Single Dose Azithromycin versus Ciprofloxacin
for Cholera in Children A Randomized Controlled
Trial
4Background
- Cholera significant health concern
- Ciprofloxacin effective
- Flouroquinolone resistance hence alternatives
required - Oral single-dose azithromycin good results in
adults - Children no similar studies
5Aim
Treatment efficacy of single dose Azithromycin
versus Ciprofloxacin in children with cholera
6Objectives
- To compare clinical success of single dose
treatment with Azithromycin and with
Ciprofloxacin in children with cholera - To compare bacteriological success of single dose
treatment with Azithromycin and with
Ciprofloxacin in children with cholera
7- Setting Departments of ABCD and EFGH, University
College of Medical Sciences and GTB Hospital,
Delhi. - Study Design Randomized, open labeled, clinical
controlled trial. - Study Period November 2017-March 2019
- Consent and Ethics Written informed consent and
Institutional Ethical Clearance
8Participants
- Inclusion criteria
- Children (2-12 years) with (all three)
- Acute watery diarrhea (24 h)
- Severe dehydration,
- Positive for V. cholerae by HD examination or
stool culture - Exclusion criteria
- Severe under-nutrition
- Co-existing systemic illness
- Blood in stool
- Receiving antibiotic/antidiarrheal within
preceding 24 h
9Sample size
- Equivalence study
- At least 87 patients (each group) to ensure
- difference in clinical success rate between
groups should not exceed 10 - Power 80
- a error 5
- ß error 20
- Khan WA, et al. Randomised controlled comparison
of single-dose ciprofloxacin and doxycycline for
cholera caused by Vibrio cholerae 01 or 0139.
Lancet. 1996348(9023)296-300.
10Methods
- Randomization Simple
- Allocation sealed envelope technique
- Intervention Immediate rehydration (WHO
Guidelines) followed by - Oral azithromycin 20 mg/kg, dispersible tab
single dose - Oral ciprofloxacin 20mg/kg dispersible tab
single dose - Monitoring 8 hourly (from drug delivery)
- Time of discharge 72 hours (day 3) or until
resolution of watery diarrhea, whichever is
later. - Follow-up visit day 7
11Bacteriological procedures
- Stool collection Fresh stool / rectal swab
- Hanging drop examination
- Transport Alkaline peptone water/ Cary Blair
media. - Stool culture Bile salt agar, Mac Conkey agar
and thiosulphate citrate bile sucrose agar. - Incubation 37ºC for 24 hours
- Enrichment alkaline peptone water
- Serotyping Slide agglutination test
- Antimicrobial susceptibility testing Kirby-Bauer
disc diffusion techinque
12Outcome measures
Primary
Secondary
- Clinical success (resolution of diarrhea within
72 hrs ) - Bacteriological success (cessation of Vibrio
cholerae excretion by day 3)
- Recovery Time total duration of diarrhea
- Total requirement of ORS/ intravenous therapy
- Proportion of children with clinical or
bacteriological relapse
13Statistical analysis
- Chi-square/Fishers exact test to compare
frequency of - Clinical and Bacteriological success
- Clinical or bacteriological relapse
- Unpaired t-test to compare
- Duration of diarrhea excretion of Vibrio
- requirement of RL and ORS
- Significance _at_ Plt0.05
- Repeated measure ANOVA for variables like mean
frequency of stool (Days 1, 2, 3 and 7) and
vomiting _at_1 level of significance to allow
multiple comparisons
14Thank you!